Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Interest Coverage Ratio (2020 - 2025)

Historic Interest Coverage Ratio for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to 1158.92.

  • Barinthus Biotherapeutics' Interest Coverage Ratio fell 11003.94% to 1158.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 1647.6, marking a year-over-year decrease of 2248.3%. This contributed to the annual value of 1282.45 for FY2024, which is 5720.78% up from last year.
  • According to the latest figures from Q3 2025, Barinthus Biotherapeutics' Interest Coverage Ratio is 1158.92, which was down 11003.94% from 1943.67 recorded in Q2 2025.
  • In the past 5 years, Barinthus Biotherapeutics' Interest Coverage Ratio ranged from a high of 8.84 in Q1 2022 and a low of 2855.43 during Q4 2023
  • Over the past 5 years, Barinthus Biotherapeutics' median Interest Coverage Ratio value was 1523.83 (recorded in 2024), while the average stood at 1390.64.
  • In the last 5 years, Barinthus Biotherapeutics' Interest Coverage Ratio crashed by 2519124.88% in 2021 and then surged by 47946.0% in 2022.
  • Barinthus Biotherapeutics' Interest Coverage Ratio (Quarter) stood at 926.0 in 2021, then soared by 100.95% to 8.84 in 2022, then crashed by 32409.13% to 2855.43 in 2023, then soared by 31.74% to 1949.17 in 2024, then surged by 40.54% to 1158.92 in 2025.
  • Its last three reported values are 1158.92 in Q3 2025, 1943.67 for Q2 2025, and 1584.62 during Q1 2025.